Agonist independent tonic inhibitory influence of G(i) on adenylate cyclase activity in rabbit ventricular myocardium and its removal by pertussis toxin: A role of empty receptor mediated G(i) activation

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 765-775

  Akaishi, Yasuhiro ^a   Hattori, Yuichi ^a   Kanno, Morio ^a   Sakuma, Ichiro ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adenylate cyclase; Cardiac membranes; G(i); Guanine nucleotides; Muscarinic receptors; Pertussis toxin; Rabbit heart; adrenoceptors

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADENYLATE CYCLASE; ATROPINE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE; GUANOSINE TRIPHOSPHATE; GUANYLYLIMIDODIPHOSPHATE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; PERTUSSIS TOXIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE FIBER MEMBRANE; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0031079669     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0315     Document Type: Article

References (44)

1. BIRNBAUMER L, 1990a. G proteins in signal transduction. Annu Rev Pharmacol Toxicol 30: 675-705.
2. BIRNBAUMER L, ABRAMOWITZ J, BROWN AM, 1990b. Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031: 163-224.
3. BÖHM M, GIERSCHIK P, JAKOBS KH, SCHNABEL P, KEMKES B, ERDMANN E, 1989. Localization of a "postreceptor" defect in human dilated cardiomyopathy. Am J Cardiol 64: 812-814.
4. 1 adenosine receptors in human myocardium. Am J Physiol 266: H1951-H1958.
5. BOKOCH GM, KATADA T, NORTHUP JK, UI M, GILMAN AG, 1984. Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 259: 3560-3567.
6. BOURNE HR, SANDERS DA, MCCORMICK F, 1990. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348: 125-132.
7. BRISTOW MR, GINSBURG R, MINOBE W, CUBICCIOTTI RS, SAGEMAN WS, LURIE K, BILLINGHAM ME, HARRISON DC, STINSON EB, 1982. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211.
8. BROWN LA, HARDING SE, 1992. The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure. Br J Pharmacol 106: 115-122.
9. CERIONE RA, CODINA J, BENOVIC JL, LEFKOWITZ RJ, BIRNBAUMER L, CARON MG, 1984. The mammalian beta 2-adrenergic receptor: Reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. Biochemistry 23: 4519-4525.
10. CERIONE RA, STANISZEWSKI C, GIERSCHIK P, CODINA J, SOMERS RL, BIRNBAUMER L, SPIEGEL AM, CARON MG, LEFKOWITZ RJ, 1986. Mechanism of guanine nucleotide regulatory protein-mediated inhibition of adenylate cyclase: studies with isolated subunits of transducin in a reconstituted system. J Biol Chem 261: 9514-9520.
11. CHIDIAC P, HEBERT TE, VALIQUETTE M, DENNIS M, BOUVIER M, 1994. Inverse agonist activity of β-adrenergic antagonists. Mol Pharmacol 45: 490-499.
12. ECKBERG DL, DRABINSKY M, BRAUNWALD E, 1971. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883.
13. ENDOH M, MURAYAMA M, TAIRA N, 1983. Modification by islet-activating protein of direct and indirect inhibitory actions of adenosine on rat atrial contraction in relation to cyclic nucleotide metabolism. J Cardiovasc Pharmacol 5: 131-142.
14. FELDMAN AM, COPELAS L, GWATHMEY JK, PHILLIPS P, WARREN SE, SCHOEN FJ, GROSSMAN W, MORGAN JP, 1987. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75: 331-339.
15. FELDMAN AM, CATES AE, VEAZEY WB, HERSHBERGER RE, BRISTOW MR, BAUGHMAN KL, BAUMGARTNER WA, VAN DOP C, 1988. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82: 189-197.
16. FLEMING JW, STRAWBRIDGE RA, WATANABE AM, 1987. Muscarinic receptor regulation of cardiac adenylate cyclase activity. J Mol Cell Cardiol 19: 47-61.
17. FLEMING JW, WISLER PL, WATANABE AM, 1992. Signal transduction by G proteins in cardiac tissues. Circulation 85: 420-433.
18. GILMAN AG, 1987. G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 56: 615-649.
19. GILMAN AG, 1992. Adenylyl cyclases. Cell 70: 869-872.
20. + currents in frog and rat cardiac cells. L Physiol (Lond) 461: 743-765.
21. HAZEKI O, UI M, 1981. Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells. J Biol Chem 256: 2856-2862.
22. HESCHELER J, KAMEYAMA M, TRAUTWEIN W, 1986. On the mechanism of muscarinic inhibition of the cardiac Ca current. Pflügers Arch 407: 182-189.
23. HILF G, JAKOBS KH, 1992. Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur J Pharmacol (Mol Pharmacol Sect) 225: 245-252.
24. HULME EC, BIRDSALL NJM, BUCKLEY NJ, 1990. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30: 633-673.
25. + channel in atrial myocytes of guinea pig heart. J Gen Physiol 98: 517-533.
26. KATADA T, BOKOCH GM, NORTHUP JK, UI M, GILMAN AG, 1984a. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the puridied protein. J Biol Chem 259: 3568-3577.
27. KATADA T, NORTHUP JK, BOKOCH GM, UI M, GILMAN AG, 1984b. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase: Subunit dissociation and guanine nucleotide-dependent hormonal inhibition. J Biol Chem 259: 3578-3585.
28. KATADA T, OINUMA M, UI M, 1986. Mechanisms for inhibition of the catalytic activity of adenylate cyclase by the guanine nucleotide-binding proteins serving as the substrate of islet-activating protein, pertussis toxin. J Biol Chem 261: 5215-5221.
29. LIANG BT, GALPER JB, 1988. Differential sensitivity of alpha o and alpha i to ADP-ribosylation by pertussis toxin in the intact cultured embryonic chick ventricular myocyte: Relationship to the role of G proteins in the coupling of muscarinic cholinergic receptors to inhibition of adenylate cyclase activity. Biochem Pharmacol 37: 4549-4555.
30. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ, 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
31. MEWES T, DUTZ S, RAVENS U, JAKOBS KH, 1993. Activation of calcium currents in cardiac myocytes by empty β-adrenoceptors. Circulation 88: 2916-2922.
32. MURAYAMA T, UI M, 1985. Receptor-mediated inhibition of adenylate cyclase and stimulation of arachidonic acid release in 3T3 flbroblasts. J Biol Chem 260: 7226-7233.
33. i-proteins in heart failure. Lancet ii: 936-937.
34. NORTHUP JK, SMIGEL MD, GILMAN AG, 1982. The guanine nucleotide activating site of the regulatory component of adenylate cyclase. J Biol Chem 257: 11416-11423.
35. NORTHUP JK, SMIGEL MD, STERNWEIS PC, GILMAN AG, 1983. The subunits of the stimulatory regulatory component of adenylate cyclase. Resolution of the activated 45,000-Dalton (alpha) subunit. J Biol Chem 258: 11369-11376.
36. OSAKA T, JOYNER RW, 1992. Developmental changes in the β-adrenergic modulation of calcium currents in rabbit ventricular cells. Circ Res 70: 104-115.
37. SALOMON Y, 1979. Adenylate cyclase assay. In: Brooker G, Greengard P, Robinson GA (eds). Advances in Cyclic Nucleotide Research, Vol. 10. New York: Raven Press, 35-55.
38. 2-adrenergic receptor. Mol Pharmacol 45: 390-394.
39. i proteins: Effects of pertussis toxin. Mol Endocrinol 3: 1115-1124.
40. iα. Science 261: 218-221.
41. WATANABE AM, 1983. Pharmacological modification of cardiac function: cholinergic agonists and antagonists. In: Hoffman BF, Rosen MR (eds). Cardiac Therapy. New York: Martinus Nijhoff, 95-144.
42. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47: 322-329.
43. ZHANG L, BUXTON ILO, 1991. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways. Mol Pharmacol 40: 952-959.
44. ZIPES DP, 1984. Cardiac arrhythmias: diagnosis and treatment. In: Braunwald E (ed.). Heart diseases. A Textbook of Cardiovascular Medicine. Philadelphia: Saunders, 683-743.